Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779-1
<p><b>Copyright information:</b></p><p>Taken from "Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779"</p><p>http://www.biomedcentral.com/1471-2210/7/14</p><p>BMC Pharmacology 2007;7():14-14.</p><p>Published online 6 Nov 2007</p><p>PMCID:PMC2213639.</p><p></p
